Overview of Flufenal

Quick Facts

Property	Description
Active ingredient	Flunarizine
Form	Tablet / Capsule
Pharmacological class	Selective Calcium Channel Blocker (Calcium Antagonist)
Common use	Prophylaxis (Preventive stabilization)
Origin	Synthetic

What is Flufenal and What is it Made Of?

Flufenal is a medicinal preparation whose active component is Flunarizine. This drug is classified as prescription-only (Rx), primarily manufactured and distributed in several international markets. It is a synthetic, single-component compound typically manufactured for oral administration in the form of tablets or capsules. Flufenal is essentially a brand name containing the generic substance Flunarizine.

Flunarizine is identified as a diphenylmethylpiperazine derivative. The core purpose of this compound is to selectively target certain cells and blood vessels to manage conditions related to vascular and nerve cell instability, often targeting adult patient groups. Pharmacological studies support its stabilizing effects on these tissues.

What Type of Medicine is Flunarizine?

Flunarizine belongs to the pharmacological group known as Selective Calcium Channel Blockers (or Calcium Antagonists). This means the drug's primary action involves stabilizing the flow of calcium ions in and out of the body’s cells, a process essential for reducing cellular hyperactivity.

Flunarizine is a calcium entry blocker with additional antihistamine and dopamine receptor blocking properties. This indicates the medicine has a unique, broad stabilizing effect that is effective in the nervous system, which is clinically recognized for its use in preventive therapy.

What is the General Purpose of Flufenal?

The general therapeutic purpose of Flufenal is to act as a prophylactic and stabilizing agent for systems prone to cellular stress and hyperactivity. Its role is to help maintain equilibrium in the vascular and nervous systems.

By blocking the excessive entry of calcium into vulnerable cells, Flunarizine helps maintain appropriate nerve and muscle function. Flunarizine's primary function is to stabilize cell membranes and reduce the severity of problems linked to vascular and neural over-excitability. Flunarizine serves as a key preventive agent against instability and hyper-reactivity, often used in situations requiring long-term functional stability.

What side effects are possible with Flufenal?

Possible Side Effects and Safety Information

The safety profile for Flufenal, containing the active ingredient Flunarizine, is organized by regulatory agencies based on the affected System Organ Classes and the frequency of occurrence. The officially documented adverse reactions primarily concern the Central Nervous System and Psychiatric Disorders.

Frequency-Classified Adverse Reactions

The most frequently reported effects, classified as Very Common (ge 1/10) in official labeling, include weight increase. Reactions listed as Common (ge 1/100 to < 1/10) include somnolence (drowsiness), depression, and fatigue. Less frequent, Uncommon effects (ge 1/1,000 to < 1/100) include anxiety, insomnia, nausea, constipation, muscle weakness, and irregular menstruation.

Serious Adverse Reactions and Safety Constraints

The most serious regulatory concerns involve the risk of developing Extrapyramidal Symptoms and Depression. Extrapyramidal symptoms, which include conditions like Parkinsonism and tremor, are classified as Not Known in frequency but are explicitly highlighted as significant safety risks. The risk for both depression and extrapyramidal symptoms may increase with prolonged treatment (long-term exposure).

Flufenal is contraindicated and should not be used in individuals with a history of depressive illness or pre-existing Parkinson's disease or other extrapyramidal disorders. Regulatory documents also note that older adults are at a higher documented risk for developing these serious effects.

Overdose and Emergency Response

Overdose and when to seek help

This section describes the officially documented manifestations and mandated emergency actions for Flufenal (Flunarizine) overdose, strictly according to regulatory labeling.

Documented Overdose Presentations

Acute overdosage cases, including those involving single intakes up to 600 mg, have resulted in specific documented clinical signs. Based on official prescribing information, the observed symptoms primarily affect the central nervous system and cardiovascular system. Symptoms include pronounced sedation, agitation, and confusion. A cardiovascular effect, tachycardia (rapid heart rate), has also been documented. Additionally, asthenia (extreme weakness or lack of energy) may be an expected symptom based on the pharmacological profile of the drug.

Emergency Actions and Treatment

Immediate medical attention must be sought for any suspected or confirmed acute overdosage. Treatment of acute overdosage is based entirely on supportive and symptomatic care to manage the documented clinical manifestations. Procedural interventions described in official labeling include the potential use of gastric lavage or charcoal administration, if deemed appropriate by healthcare professionals, to reduce drug absorption. It is explicitly documented in the regulatory profile that no specific antidote is known for Flunarizine overdose, reinforcing the focus on symptomatic management.

Therapeutic Uses of Flufenal

What Flufenal Treats: Main Uses and Benefits

Flufenal (Flunarizine) is commonly used to help with conditions presenting with systemic or localized discomfort and recurrent manifestations. It is considered relevant for offering prophylactic support and assisting with the overall symptom load of disruptive episodes.

Prophylactic Support and Symptom Relief

This medication is applied in the context of long-term preventive treatment for patients experiencing symptoms associated with acute or episodic changes. It is relevant for managing symptom clusters that may become intense or disruptive, such as severe recurrent headaches, nausea, vomiting, or sensations of spinning. This approach contributes to easing the overall symptom load. The therapy is commonly used to help with symptoms that interfere with daily functioning.

In settings involving imbalance and disequilibrium, Flufenal is applied in addressing distressing manifestations that stem from vestibular system dysfunction. It assists with maintaining a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Recurrent Headache & Vestibular Symptoms

Regulatory References

NIH MeSH Database

Eligibility and Restrictions for Use

This section outlines official eligibility and non-eligibility requirements for Flufenal, based strictly on regulatory documents (such as FDA and EMA labeling).

Populations for whom use is Contraindicated

Flufenal must not be used by individuals with certain pre-existing conditions or physiological states. Contraindications include known hypersensitivity to flufenal or other related compounds. Use is also prohibited in patients with confirmed liver damage, blood dyscrasia (severe blood disorders), suspected or established subcortical brain damage, or those in comatose or severely depressed states. It is also contraindicated for patients receiving large doses of hypnotics.

Age and Physiological Restrictions

The medicine is generally not intended for use in children under 12 years of age, as safety and efficacy in this pediatric group have not been established. For older adults with dementia-related psychosis, use is not approved and carries a regulatory warning regarding increased mortality risk. During pregnancy and lactation, Flufenal should generally be avoided since safety has not been established.

Eligibility-Related Restrictions

Caution is advised and use may be restricted for patients with a history of convulsive disorders (seizures) or certain cardiovascular diseases.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Flufenal (Flunarizine), based strictly on government regulatory labeling and prescribing information.

Pharmacokinetic Interactions (Altered Exposure)

Co-administration with enzyme-inducing anticonvulsants (such as Phenytoin, Carbamazepine, and Valproate) leads to reduced Flunarizine plasma concentrations due to enhanced first-pass metabolism. Conversely, the co-administration of Topiramate is officially documented to increase Flunarizine systemic exposure (AUC) by 16%. Flunarizine does not significantly affect the pharmacokinetics of these co-administered anticonvulsants.

Pharmacodynamic and Substance Interactions

Combining Flunarizine with alcohol or other Central Nervous System (CNS) depressants (including sedatives and tranquilizers) carries the regulatory warning of potential excessive sedation due to an additive effect. This effect represents a significant pharmacodynamic interaction. Co-administration with anti-hypertensive drugs may lead to low blood pressure and may require a dosage adjustment of the anti-hypertensive agent, according to official regulatory cautions. Additionally, Flunarizine has been associated with galactorrhoea in female patients using oral contraceptives.

Population-Specific Cautions

Regulatory documentation includes a caution that hepatic impairment (compromised liver function) requires careful administration, as Flunarizine is extensively metabolized by the liver, raising the potential for altered clearance and increased systemic exposure.

Mechanism of Action

How Flufenal Works

Flunarizine's mechanism of action is based on the modulation of ion conductance and receptor activity in excitable tissues.

Selective Modulation of Neuronal and Vascular Calcium Channels

The primary action of Flunarizine is the blockade of calcium ions ( Ca^2+) through specific voltage-dependent calcium channels, especially the T-type ( Ca v3.x) in neurons. This interaction raises the threshold required for nerve cells to fire an action potential, resulting in a modulation of neuronal membrane potential and a reduction in spontaneous firing frequency. Furthermore, by blocking L-type channels in vascular smooth muscle, the drug induces vasodilation in cerebral vasculature, which alters local blood flow dynamics.

Antagonism of Histamine and Dopamine Pathways

Flunarizine also functions as an antagonist at several central neurotransmitter receptors, including the Histamine H1 and Dopamine D2 receptors. This secondary mechanism modulates signaling pathways in the central nervous system, affecting the final integrated output of neural circuits. This engagement affects H1 and D2 receptor-mediated responses, influencing neurotransmission dynamics beyond direct membrane conductance.

Dosage and Administration Information

How to use Flufenal (Fluphenazine Decanoate Injection, USP) — Administration Guidelines

This medication is a long-acting injectable solution that must be administered solely by a healthcare professional via intramuscular (IM) or subcutaneous (SC) injection. It must not be administered intravenously. The injection is typically given deep into the gluteal muscle.

Dosing and Frequency

Administration Scope	Guidelines
Route of administration	Intramuscular (IM) or Subcutaneous (SC) injection only.
Initial Dosing	12.5 mg to 25 mg (0.5 mL to 1 mL) is the suggested starting dose.
Maintenance Frequency	Subsequent doses are determined by patient response and are repeated every two to five weeks.
Maximum Dose	Subsequent injections should not exceed 100 mg.

Administration Requirements

Prior to use, the solution, which is clear and pale yellow, must be visually inspected for any particulate matter or discoloration. Flufenal should not be diluted and must be drawn up using a dry syringe and a needle of at least 21-gauge.

Age-Specific Use: This injection is not intended for use in children under 12 years of age as safety and efficacy have not been established in this population.

Missed Dose Instructions: If a scheduled long-acting injection is missed, patients should contact their healthcare provider to receive the dose as soon as possible, and a new dosing schedule will be determined. Do not double the dose to make up for a missed one.

Procedural Step: After the initial injection, the patient must be kept in a recumbent position for at least 30 minutes to minimize the risk of hypotensive effects, a precaution that may be modified for ambulatory patients once the dose is stabilized.

Recent Clinical Evidence

Flufenal: Recent Clinical Evidence

Evidence for Migraine Prophylaxis (Severe Recurrent Headaches)

Research for Flunarizine (the active ingredient in Flufenal) was studied for its use in individuals with conditions characterized by fluctuating or episodic manifestations, such as severe recurrent headaches. The core evidence consists of Randomized Controlled Trials (RCTs) and is summarized by Systematic Reviews and Meta-analyses. These studies monitored outcomes related to physical discomfort by measuring endpoints like the change in the number of migraine headaches monitored per month. Studies reported data on patterns observed over short-term and intermediate-term follow-up periods, exploring how symptoms were measured during periods of heightened activity.

Evidence for Vestibular Symptoms (Dizziness and Imbalance)

Flunarizine was evaluated in studies examining its potential role in conditions involving periods of heightened symptoms related to systemic or functional imbalance, such as dizziness or vertigo that may arise from vestibular system dysfunction. The research in this area includes Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies research examined outcomes reflecting daily functioning by monitoring the rate and occurrence of vertigo attacks and using specialized scales. Studies reported data on patterns observed over generally short-term follow-up durations. However, the evidence is limited, and certainty remains low due to the size and design of the available studies.

Gaps, Limitations, and Areas of Research Uncertainty

The research landscape highlights several limitations. Many primary efficacy trials are older, reflecting studies predating the use of current standardized endpoints. Research has explored outcomes over defined time intervals, but for both indications, long-term effects are not fully established. Evidence was evaluated in specific groups like children and adolescents, but data for certain groups remain insufficient, with evidence quality varying across studies. Additionally, comparative evidence is lacking in some key areas, and study results reflect the specific conditions under which they were conducted.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Flufenal (FAQ)

Q: What is the risk of stomach upset with Flufenal?

A: According to official product information, gastrointestinal effects such as nausea and constipation are listed as uncommon side effects. These effects occur in less than 1 out of 100 people. General stomach discomfort has also been reported as a potential side effect.

Q: What are the signs of a serious allergic reaction to Flufenal?

A: The official product information states that Flufenal should not be used by individuals with a known hypersensitivity (severe allergy) to the drug. Signs of a serious allergic reaction typically include symptoms like hives, rash, severe itching, swelling of the face, tongue, or throat, or difficulty breathing. These situations require immediate medical attention.

Q: What is the typical length of time people take Flufenal?

A: For its use in migraine prophylaxis, treatment is sometimes initiated for a trial period, such as two months. If no significant improvement is seen during this time, the treatment regimen is usually re-evaluated by the prescriber. The official documentation notes that the optimal duration for long-term therapy has not been definitively established.

Q: Does Flufenal cause drowsiness or make you tired?

A: Yes, somnolence (drowsiness) and fatigue (tiredness) are explicitly listed as common side effects of Flufenal, occurring in more than 1 out of 100 people. Any changes in the severity of fatigue or drowsiness should be discussed with the prescribing physician.

Q: Can Flufenal be taken on an empty stomach?

A: Regulatory information indicates that Flufenal (Flunarizine) can generally be taken with or without food. Taking it with a meal or a snack may sometimes help reduce the chance of experiencing minor gastrointestinal discomfort.

Q: Will taking Flufenal affect my ability to drive?

A: Official warnings state that Flufenal may cause side effects such as dizziness, drowsiness, tiredness, or visual disturbances. It is advised that individuals should not drive or operate heavy machinery until they understand the medication's effects on their concentration and reaction abilities.

Q: Is there a generic version of Flufenal available?

A: Flufenal is a brand name for the active ingredient Flunarizine. Flunarizine is available in many countries in various generic formulations, which may be sold under different names. Flufenal is not widely marketed in the U.S. or U.K.

Q: How long does Flufenal stay in your system?

A: The elimination half-life of Flunarizine following multiple doses is approximately 18 to 19 days. This prolonged half-life indicates that the substance stays in the body for an extended period.

Q: Does Flufenal help with muscle spasms or only inflammation?

A: Flufenal's primary indication is for the prophylaxis of migraine and vestibular symptoms, and its action is based on calcium channel modulation. Regulatory documents do not list use for treating muscle spasms or inflammation directly, although some adverse reactions like muscle twitching have been reported.

Q: Are there any known interactions between Flufenal and herbal supplements?

A: Official regulatory warnings focus on interactions with specific medications, such as CNS depressants and certain anticonvulsants. It is important that all over-the-counter products, including herbal tonics and supplements, be reviewed by a healthcare professional.

Q: Can Flufenal be crushed or cut in half?

A: Regulatory and manufacturer instructions for Flunarizine tablets often include the caution to swallow the medication whole and not to chew or crush the tablet. This caution is generally given to ensure the proper drug release and absorption.

Q: Is Flufenal available over-the-counter in some countries?

A: Flufenal (Flunarizine) is classified internationally as a prescription-only (Rx) medication in the countries where it is marketed. It is not generally available for purchase without a doctor's prescription.

Q: Does Flufenal have a known risk of kidney problems?

A: Official patient information advises that caution is necessary for individuals with a history of kidney conditions or diseases. A full medical assessment is essential before use to determine appropriateness, as dose adjustments may be needed.

Q: Are there specific dietary restrictions while taking Flufenal?

A: There are no mandatory dietary restrictions explicitly listed in regulatory documents. However, due to the common side effect of weight increase, maintaining a healthy, balanced diet is generally recommended when taking this medication.

Q: Is Flufenal considered a strong pain medication?

A: No. Flufenal (Flunarizine) is a Selective Calcium Channel Blocker used for prophylaxis (prevention) of conditions like migraine or vertigo. It is not classified or indicated as a strong medication for treating acute or severe pain.

Q: Can Flufenal be used to treat fevers?

A: No. The official and approved indications for Flufenal are for migraine prophylaxis and the treatment of vertigo/dizziness of vestibular origin. It is not indicated or approved for treating fever.

Q: Is Flufenal a controlled substance?

A: No. Official regulatory classification and legal status confirm that Flufenal (Flunarizine) is a prescription drug but is not designated as a controlled or habit-forming substance.

Q: Is it possible to become dependent on Flufenal?

A: According to official regulatory and legal classifications, Flufenal (Flunarizine) is not considered a habit-forming drug. There is no dependency risk associated with its use.

Q: Does taking Flufenal require regular blood tests?

A: While regulatory documents do not universally mandate specific blood tests, they emphasize that patients should be seen by a doctor at regular intervals during long-term maintenance treatment. This is primarily to monitor for the potential development of serious side effects like Extrapyramidal Symptoms or depression.

Q: Can Flufenal be taken with certain vitamins, like Vitamin D or B12?

A: Specific interactions with individual vitamins, such as Vitamin D or B12, are not generally listed in the core regulatory documents. It is important to have all over-the-counter products, including vitamins and supplements, reviewed by a healthcare professional.

Q: Do you have to take Flufenal with food to prevent stomach issues?

A: Flufenal can be taken with or without food. Taking it with food may be advised to minimize the chance of minor gastrointestinal discomfort, but it is not a mandatory requirement for absorption.

Q: How does Flufenal affect blood thinning or clotting?

A: Pre-clinical studies and regulatory information indicate that the active ingredient in Flufenal generally does not possess antithrombotic activity. It has been observed not to significantly affect blood clotting parameters like platelet aggregation or bleeding time.

Q: What should be done if I accidentally take two doses close together?

A: Individuals should not attempt to double the next scheduled dose. Due to the drug's long half-life, an accidental extra dose can lead to drug accumulation and an increased risk of side effects. Contact with a healthcare provider is recommended immediately in this situation.

How should Flufenal be stored and disposed of?

How to Store and Dispose of Flufenal?

As of the current regulatory records, no specific storage, handling, or disposal requirements have been officially published by major governmental health agencies (such as the FDA, EMA, Health Canada, or NIH/MedlinePlus) for a drug product named Flufenal.

Without explicit, labeled instructions, the storage and disposal procedures for Flufenal are based on general governmental guidance for medications:

General Storage: Medicines should typically be stored in a cool, dry place, away from direct heat, moisture, and light, and kept out of the reach of children and pets. Do not store medicine in a bathroom medicine cabinet.
Disposal: The best option for disposal of unused or expired medicines is through a local drug take-back program or using an authorized mail-back envelope. If those options are not readily available and the drug is not on a regulatory agency's list of medicines recommended for flushing, dispose of it in the household trash after mixing it with an unappealing substance like dirt or used coffee grounds, and sealing the mixture in a container to prevent leakage.

Flufenal